Search hospitals

>

Iowa

>

Clive

Mercy Cancer Center-West Lakes

Claim this profile

Clive, Iowa 50325

Global Leader in Lung Cancer

Global Leader in Breast Cancer

Conducts research for Cancer

Conducts research for Breast cancer

Conducts research for Ovarian Cancer

279 reported clinical trials

2 medical researchers

Photo of Mercy Cancer Center-West Lakes in ClivePhoto of Mercy Cancer Center-West Lakes in Clive

Summary

Mercy Cancer Center-West Lakes is a medical facility located in Clive, Iowa. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Breast cancer, Ovarian Cancer and other specialties. Mercy Cancer Center-West Lakes is involved with conducting 279 clinical trials across 419 conditions. There are 2 research doctors associated with this hospital, such as Richard L. Deming and Mehmet S. Copur.

Area of expertise

1

Lung Cancer

Global Leader

Mercy Cancer Center-West Lakes has run 52 trials for Lung Cancer. Some of their research focus areas include:

Stage IV
Stage II
Stage III
2

Breast Cancer

Global Leader

Mercy Cancer Center-West Lakes has run 45 trials for Breast Cancer. Some of their research focus areas include:

HER2 negative
Stage IV
ER positive

Top PIs

Clinical Trials running at Mercy Cancer Center-West Lakes

Bladder Cancer

Lung Cancer

Breast Cancer

Cancer

Colorectal Cancer

Prostate Cancer

Melanoma

Multiple Myeloma

Bladder Carcinoma

Breast cancer

Image of trial facility.

Eribulin + Chemotherapy

for Bladder Cancer

This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.

Recruiting

2 awards

Phase 3

Image of trial facility.

Pembrolizumab + Radiation

for Bladder Cancer

This phase II trial compares the use of pembrolizumab and radiation therapy to chemotherapy with cisplatin, gemcitabine, 5-fluorouracil or mitomycin-C and radiation therapy for the treatment of non-muscle invasive bladder cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, gemcitabine, 5-fluorouracil or mitomycin-C, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Giving pembrolizumab with radiation may kill more tumor cells than chemotherapy with radiation therapy in patients with non-muscle invasive bladder cancer.

Recruiting

1 award

Phase 2

9 criteria

Image of trial facility.

Blood Sample Collection

for Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.

Recruiting

1 award

N/A

9 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Mercy Cancer Center-West Lakes?